The 2018 Academy Awards' Best Picture race is one of the most unpredictable in recent memory. Cinemablend's Sean O'Connell joins Cheddar to break down the biggest storylines heading into Hollywood's biggest night. The ceremony's drama will start before the ceremony begins, as all eyes turn to the Ryan Seacrest controversy on the red carpet. O'Connell discusses whether publicists will steer their clients away from the embattled E! personality due to newly detailed allegations made against him. We also discuss the Oscars dedicating a moment of the show to the Time's Up movement. Finally, we offer our final Oscars predictions. This year, the major acting categories are expected to be dominated by the favorites who have been cleaning up all awards season long. However, Baker, Hope, and O'Connell don't see eye to eye on who will win the biggest award of the evening.

Share:
More In Culture
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
First-Time Homebuyers Face Rising Mortgage Rates
Buying a new home is tough right now; but for first-time buyers, it's an especially challenging time, with obstacles like rising mortgage rates and record-breaking home prices. The housing market is not expected to get much friendlier, as mortgage rates are expected to continue to climb as the Federal Reserve proceeds with its plans for rate hikes in an effort to stifle inflation. Jonathan Miller, President and CEO of real estate appraiser Miller Samuel, joins Cheddar News' Closing Bell to discuss.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Load More